These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17440080)

  • 1. Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells.
    Schumacher JJ; Dings RP; Cosin J; Subramanian IV; Auersperg N; Ramakrishnan S
    Cancer Res; 2007 Apr; 67(8):3683-90. PubMed ID: 17440080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
    Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
    Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo.
    Sinha S; Pal K; Elkhanany A; Dutta S; Cao Y; Mondal G; Iyer S; Somasundaram V; Couch FJ; Shridhar V; Bhattacharya R; Mukhopadhyay D; Srinivas P
    Int J Cancer; 2013 Mar; 132(5):1201-12. PubMed ID: 22806981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
    Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
    Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfection of rat ovarian surface epithelium with erb-B2/neu induces transformed phenotypes in vitro and the tumorigenic phenotype in vivo.
    Davies BR; Auersperg N; Worsley SD; Ponder BA
    Am J Pathol; 1998 Jan; 152(1):297-306. PubMed ID: 9422547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
    Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
    Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression.
    Litz J; Sakuntala Warshamana-Greene G; Sulanke G; Lipson KE; Krystal GW
    Lung Cancer; 2004 Dec; 46(3):283-91. PubMed ID: 15541812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
    Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
    Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
    Shi HR; Song WJ; Chen ZM; Wu QH
    Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
    Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S
    Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
    Zhong XS; Zheng JZ; Reed E; Jiang BH
    Biochem Biophys Res Commun; 2004 Nov; 324(2):471-80. PubMed ID: 15474452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats.
    Roman CD; Choy H; Nanney L; Riordan C; Parman K; Johnson D; Beauchamp RD
    J Surg Res; 2002 Jun; 105(1):43-7. PubMed ID: 12069500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors.
    Inan S; Vatansever S; Celik-Ozenci C; Sanci M; Dicle N; Demir R
    Histol Histopathol; 2006 Oct; 21(10):1055-64. PubMed ID: 16835828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
    Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
    Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
    Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
    Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Zhang Y; Xu Y; Ma J; Pang X; Dong M
    Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation.
    Brossa A; Grange C; Mancuso L; Annaratone L; Satolli MA; Mazzone M; Camussi G; Bussolati B
    Oncotarget; 2015 May; 6(13):11295-309. PubMed ID: 25948774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.